Optimer Pharma (OPTR) Names Stephen Webster as CFO
Tweet
Share
E-mailGet Alerts OPTR Hot Sheet
Join SI Premium – FREE
Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) has appointed Stephen Webster as Chief Financial Officer. Mr. Webster will be responsible for directing Optimer's financial strategy, accounting and investor relations functions.
Prior to joining Optimer, Mr. Webster served as Chief Financial Officer of Adolor Corporation until its sale to Cubist Pharmaceuticals, Inc.
Prior to joining Optimer, Mr. Webster served as Chief Financial Officer of Adolor Corporation until its sale to Cubist Pharmaceuticals, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sui Group's chief investment officer resigns, effective July 2026
- Ironwood names new CMO as STARS-2 trial begins recruiting
- Shutterstock CEO Paul Hennessy steps down; CFO named interim chief
Create E-mail Alert Related Categories
Management ChangesRelated Entities
Cubist Pharmaceuticals Inc./Adolor Corp.Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
